
Ronan Levy, Founder of Field Trip Ventures
by Nick Opich on August 22, 2019 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
by Nick Opich on August 22, 2019 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Ronan Levy, Founder of Field Trip Ventures sits down with The Green Rush this week as the team looks to cover something a little different: psychedelics.
Field Trip Ventures is a first-of-its-kind venture that is blending operational execution with strategic investing across all aspects of the psychedelics supply chain. From basic research on botanical psychedelics like psilocybin, to the operation of world-class clinics focused on psychedelic-assisted therapies (for example, using MDMA to treat PTSD), Ronan and his team are on the front lines of the “next cannabis.”
The Green Rush will chat with Ronan about his cannabis roots including his time as an executive with Aurora Cannabis, the re-emergence of psychedelic-based therapies, how psychedelics could follow the same “playbook” as cannabis as it looks to move towards legalization and busting common myths and misinformation around its addictiveness and dangers.
Don’t sit back, lean forward and enjoy!
Ronan Levy – Founder, Field Trip Ventures
A lawyer by training, Ronan presently serves as a founder of Field Trip Ventures, Grassfed Ventures and is on the Board of Directors of Province Brands and Proof & Concept Inc. , He is also the founder of Toronto Gold , Toronto’s most respected precious metal broker and principal at TDF Advisory Law Professional Corporation. Ronan started his career as a corporate lawyer at Blake, Cassels Graydon LLP and Legal Counsel at CTVglobemedia Inc. (now Bell Media Inc.) He holds a Juris Doctor and a Bachelor of Commerce degree, both from the University of Toronto.
Links and mentions in the show
Links to the guest’s company and social media accounts
Show Credits:
This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications.
Special thanks to our Executive Producer Nick Opich Program Director Shea Gunther at Marijuana Today
You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
Twitter: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/
Facebook: https://www.facebook.com/TheGreenRushPodcast/
YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Nick Opich and Anne Donohoe are back for a new episode with special guest Sue Taylor, Co-Founder and Executive Director of The Farmacy, a family of retail stores in […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Nick Opich are back for a new episode with special guest Charles Lazarus, Chief Cultivation & Production Officer at Rose Hill. Charles joins us this week […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Nick Opich and Anne Donohoe are back for a new episode with special guest Kris Krane, Director of Cannabis Development for KCSA Strategic Communications. Kris joins us this week […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe is back, alongside first time-host – longtime producer (sorta!) and fellow KCSAer Emmaline Lewis, for a new episode with special guests Jim Fadiman, PhD, Independent Microdosing Researcher […]